Avid Bioservices Inc (CDMO)

[InternetForumUser]

Might as well join the Pfizer band wagon but thought this article was great about immunotherapy drugs. Roche, Merck and Bristol-Meyers Squibb all seem to have some sort of immunotherapy drug in clinical trials, but Pfizer does not.

A quote from the end of the article:

"Pfizer Inc., PFE -2.52% for instance, doesn't have any PD-1 or PD-L1 drugs in its pipeline, but Garry Nicholson, president of its oncology unit, said the company is interested in studying them in combination with its own targeted cancer drugs. "There are multiple ways of working out these combinations," he said."

Pfizer does seem to be making a lot of moves and it must be for a reason.

http://online.wsj.com/article/SB10001424127887323398204578485401089823868.html